Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH

The National Cancer Institute (NCI) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 4 clinical trials at NIH that match your search criteria

Cancer by type: Lymphoma, Cutaneous T-cell (CTCL)

Trial and Protocol Number Lymphoma, Cutaneous T-cell (CTCL)	Principal Investigator	Referral Contact
Phase II
A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for Treatment of CD25 Positive Cutaneous T-Cell Lymphomas NCI-04-C-0142	Robert J. Kreitman 301-496-6947	Linda Ellison 301-496-9458 ellisonl@mail.nih.gov
Phase I
Phase I Pilot Study of Topical Romidepsin in Patients With Stage IA, IB, or IIA Cutaneous T-Cell Non-Hodgkin’s Lymphoma NCI-07-C-0133	Maria L. Turner 301-496-7737	Susan Booher 301-402-1474 boohers@mail.nih.gov
No Phase
Pathogenesis and Course of Cutaneous T-Cell Lymphoma NCI-04-C-0081	Sam Hwang 301-496-8724	Susan Booher 301-402-1474 boohers@mail.nih.gov

Trial and Protocol Number Hematologic/Blood Cancers	Principal Investigator	Referral Contact
Phase I/II
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation Using HLA-Matched Unrelated Donors and Utilizing Two Graft-versus-Host Disease Prophylaxis Regimens for the Treatment of Leukemias, Lymphomas, and Pre-malignant Blood Disorders NCI-07-C-0195	Michael Bishop 301-435-2764	Bazetta (Zetta) Blacklock 301-594-2056 bblacklock@mail.nih.gov

If there are no studies listed for your specific disease type, please search under:

Solid Tumor (advanced malignancy)